Powers Advisory Group LLC Sells 187 Shares of Colgate-Palmolive (NYSE:CL)

Powers Advisory Group LLC lowered its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,133 shares of the company’s stock after selling 187 shares during the period. Powers Advisory Group LLC’s holdings in Colgate-Palmolive were worth $830,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the business. FMR LLC increased its position in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after buying an additional 2,674,807 shares during the period. Barclays PLC boosted its position in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. State Street Corp grew its holdings in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Nordea Investment Management AB raised its position in shares of Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after acquiring an additional 1,247,731 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its stake in shares of Colgate-Palmolive by 864.1% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock valued at $80,749,000 after purchasing an additional 697,168 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 1.5 %

CL opened at $90.96 on Friday. The company has a market cap of $74.31 billion, a PE ratio of 26.06, a price-to-earnings-growth ratio of 3.70 and a beta of 0.44. The company has a 50 day moving average of $91.58 and a 200 day moving average of $97.29. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same period in the prior year, the company posted $0.87 earnings per share. On average, sell-side analysts expect that Colgate-Palmolive will post 3.58 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.20%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. UBS Group reduced their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. TD Cowen decreased their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Finally, Stifel Nicolaus cut their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $102.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.